Elimination of N-(2-aminoacyl)-2,6-xylidines after intravenous infusion in dogs.
D000814:Aniline Compounds / Q000008:administration & dosage / Q000378:metabolism*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000378:metabolism*; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D007275:Injections, Intravenous; D008012:Lidocaine / Q000378:metabolism; D008297:Male; D013329:Structure-Activity Relationship; D014992:Xylenes / Q000008:administration & dosage / Q000378:metabolism
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D014992:Xylenes; D008012:Lidocaine